Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Lehn

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|August 2, 2003
Branched filaments no fungus, ovoid bodies no bacteria: Two unusual cases of mycetomaKathrin Elisabeth Douwes, Edith Schmalzbauer, Hans-Jörg Linde, et al.
Cancer|October 31, 2002
Helicobacter pylori and the risk of benign and malignant biliary tract diseaseMilutin Bulajic, Patrick Maisonneuve, Wulf Schneider-Brachert, et al.
The Lancet. Oncology|March 3, 2006
Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective studyGeorgios Meimarakis, Hauke Winter, Ilka Assmann, et al.
International Journal of Cancer|December 4, 2003
Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinomaAlexander Krah, Stephan Miehlke, Klaus-Peter Pleissner, et al.
Helicobacter|January 21, 2006
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivityDavid Antos, Wulf Schneider-Brachert, Elke Bästlein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitisLaurent Beaugerie, Michaela Metz, Frédéric Barbut, et al.
Infection and Immunity|January 27, 2004
Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancerSteffen Backert, Tobias Schwarz, Stephan Miehlke, et al.
Helicobacter|September 3, 2003
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycinStephan Miehlke, Christian Kirsch, Wulf Schneider-Brachert, et al.
Infection and Immunity|July 26, 2005
Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agentLudwig Deml, Michael Aigner, Jochen Decker, et al.
Plos One|August 14, 2013
Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tigerNicole Tegtmeyer, Francisco Rivas Traverso, Manfred Rohde, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|August 2, 2003
Branched filaments no fungus, ovoid bodies no bacteria: Two unusual cases of mycetomaKathrin Elisabeth Douwes, Edith Schmalzbauer, Hans-Jörg Linde, et al.
Cancer|October 31, 2002
Helicobacter pylori and the risk of benign and malignant biliary tract diseaseMilutin Bulajic, Patrick Maisonneuve, Wulf Schneider-Brachert, et al.
The Lancet. Oncology|March 3, 2006
Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective studyGeorgios Meimarakis, Hauke Winter, Ilka Assmann, et al.
International Journal of Cancer|December 4, 2003
Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinomaAlexander Krah, Stephan Miehlke, Klaus-Peter Pleissner, et al.
Helicobacter|January 21, 2006
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivityDavid Antos, Wulf Schneider-Brachert, Elke Bästlein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitisLaurent Beaugerie, Michaela Metz, Frédéric Barbut, et al.
Infection and Immunity|January 27, 2004
Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancerSteffen Backert, Tobias Schwarz, Stephan Miehlke, et al.
Helicobacter|September 3, 2003
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycinStephan Miehlke, Christian Kirsch, Wulf Schneider-Brachert, et al.
Infection and Immunity|July 26, 2005
Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agentLudwig Deml, Michael Aigner, Jochen Decker, et al.
Plos One|August 14, 2013
Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tigerNicole Tegtmeyer, Francisco Rivas Traverso, Manfred Rohde, et al.
Pageof 5